Cargando…
Oxaliplatin Treatment Alters Systemic Immune Responses
PURPOSE: Oxaliplatin is a platinum-based chemotherapeutic agent demonstrating significant antitumor efficacy. Unlike conventional anticancer agents which are immunosuppressive, oxaliplatin has the capacity to stimulate immunological effects in response to the presentation of damage associated molecu...
Autores principales: | Stojanovska, Vanesa, Prakash, Monica, McQuade, Rachel, Fraser, Sarah, Apostolopoulos, Vasso, Sakkal, Samy, Nurgali, Kulmira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398049/ https://www.ncbi.nlm.nih.gov/pubmed/30906773 http://dx.doi.org/10.1155/2019/4650695 |
Ejemplares similares
-
Oxaliplatin-induced changes in microbiota, TLR4+ cells and enhanced HMGB1 expression in the murine colon
por: Stojanovska, Vanesa, et al.
Publicado: (2018) -
Role of the nervous system in cancer metastasis
por: Kuol, Nyanbol, et al.
Publicado: (2018) -
Chemotherapy-Induced Constipation and Diarrhea: Pathophysiology, Current and Emerging Treatments
por: McQuade, Rachel M., et al.
Publicado: (2016) -
Role of oxidative stress in oxaliplatin‐induced enteric neuropathy and colonic dysmotility in mice
por: McQuade, Rachel M, et al.
Publicado: (2016) -
Anti-Tumor Effects of Vitamin B2, B6 and B9 in Promonocytic Lymphoma Cells
por: Mikkelsen, Kathleen, et al.
Publicado: (2019)